Evidence map›Paper›PMID 35830804›Full record

ArticleCell reports2022

Treadmill exercise reduces α-synuclein spreading via PPARα.

Debashis Dutta, Ramesh Kumar Paidi, Sumita Raha, Avik Roy, Sujyoti Chandra, Kalipada Pahan

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 41 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 4 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 4 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Neurobiology of exercise in Parkinson's disease.Journal of Parkinson's disease · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. HUWE1 in Skeletal Muscle Prevents Muscle Fatigue via Maintaining Iron and Calcium Homeostasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  14. Review
  15. Article
  16. Prospect of Muscle-Building Supplement HMB in Alzheimer's Disease.Journal of clinical & experimental immunology · 2026
    Article
  17. Intensive multidisciplinary rehabilitation modulates serumFrontiers in cellular neuroscience · 2026
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Debashis DuttaDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Ramesh Kumar PaidiDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Sumita RahaDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Avik RoyDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA; Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA.
Sujyoti ChandraDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.
Kalipada PahanDepartment of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA; Division of Research and Development, Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA. Electronic address: kalipada_pahan@rush.edu.
Rush University Medical Center · US

Funding

Characterizing novel hippocampal drugs for Alzheimer's diseaseR01AG050431 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2016 to 2020
$2.1M
Intranasal TIDM peptide for tauopathyR21AG069229 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2020 to 2021
$550k
TLR2-interacting domain of MyD88 peptide for alpha-synucleinopathyR21NS108025 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI PAHAN, KALIPADA · 2018 to 2019
$393k
Cinnamon and its metabolite sodium benzoate in ParkinsonismI01BX003033 · VA · JESSE BROWN VA MEDICAL CENTER · PI PAHAN, KALIPADA · 2016 to 2020
–
Cinnamon and traumatic brain injuryI01BX005002 · VA · JESSE BROWN VA MEDICAL CENTER · PI PAHAN, KALIPADA · 2020 to 2024
–
BLR&D Research Career Scientist ApplicationIK6BX004982 · VA · JESSE BROWN VA MEDICAL CENTER · PI KALIPADA PAHAN · 2020 to 2026
–
BLRD VA I01 BX003033BLRD VA I01 BX005002BLRD VA IK6 BX004982NIA NIH HHS R01 AG050431NIA NIH HHS R21 AG069229NINDS NIH HHS R21 NS108025
6 · The paper itself

Abstract

This study underlines the importance of treadmill exercise in reducing α-synuclein (α-syn) spreading in the A53T brain and protecting nigral dopaminergic neurons. Preformed α-syn fibril (PFF) seeding in the internal capsule of young A53T α-syn mice leads to increased spreading of α-syn to substantia nigra and motor cortex and concomitant loss of nigral dopaminergic neurons. However, regular treadmill exercise decreases α-syn spreading in the brain and protects nigral dopaminergic neurons in PFF-seeded mice. Accordingly, treadmill exercise also mitigates α-synucleinopathy in aged A53T mice. While investigating this mechanism, we have observed that treadmill exercise induces the activation of peroxisome proliferator-activated receptor α (PPARα) in the brain to stimulate lysosomal biogenesis via TFEB. Accordingly, treadmill exercise remains unable to stimulate TFEB and reduce α-synucleinopathy in A53T mice lacking PPARα, and fenofibrate, a prototype PPARα agonist, reduces α-synucleinopathy. These results delineate a beneficial function of treadmill exercise in reducing α-syn spreading in the brain via PPARα.

Indexed as

alpha-SynucleinPhysical Conditioning, AnimalPPAR alphaSynucleinopathiesAnimalsDisease Models, AnimalDopaminergic NeuronsMiceSubstantia Nigraalpha-SynucleinPPAR alphaCP: Neurosciencedopaminelysosomal functionParkinson’s diseasePPARαTFEBtreadmillα-synuclein

Identifiers

PMID35830804
PMCPMC9308946
OpenAlexW4285098709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.